[ 2 ] Liberman L, Bonaccio E, Bena DH, et al. Benign and Malignant Phyllodes Tumors: Mammogrophic and Sonographic Findings[J]. Radiology, 1996, 198(1): 121-124.
[3]
[ 3 ] Lee AHS, Hodi Z, Ellis IO, et al. Histological features useful in the distinction of phyllodes tumour and broadenoma on needle core biopsy of the breast[J]. Histopathology, 2007, 51(3): 336-344.
[ 5 ] Junjeong C, Ja SK. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor[J]. Pathology International, 2012, 62(2): 120-126.
[6]
[ 6 ] Mardiana AA, Frank S, Michael JK, et al. Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature[J]. Pathol Resear Inter, 2010, 10: 4061-4069.
[7]
[ 7 ] McKenzie CA, Philips J. Malignant phyllodes tumor metastatic to the lung with osteogenic differentiation diagnosed on fine needle aspiration biopsy[J]. Acta Cytol, 2002, 46(4): 718-722.
[8]
[ 8 ] Manoj P, Aleyamma M, Elizabeth KA, et al. Primary Sarcoma of the Breast [J]. J Surg Oncol, 2004, 87(3): 121-125.
Flavia MV, Ana MG, Kristine B, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast[J]. Breast J，2007，13(6): 551-556.
[11]
Tse GM, Lui PC, Scolyer RA, et al. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors[J]. Mod Pathol, 2003, 16(10): 1007-1013.
[12]
Shpitz B, Bomstein Y, Sternberg A, et al. Immunoreactivity of p53, Ki67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features[J]. J Surg Oncol, 2002, 79(2): 86-92.
[13]
Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast the role of pathologic parameters[J]. Ame J Clin Pathol, 2005, 123(2): 529-540.
